4/A//SEC Filing
Lotus Biotech Development Corp. 4/A
Accession 0001511164-16-001083
CIK 0001520592operating
Filed
Oct 16, 8:00 PM ET
Accepted
Oct 17, 10:50 AM ET
Size
4.7 KB
Accession
0001511164-16-001083
Insider Transaction Report
Form 4/AAmended
Nagy Zoltan
DirectorPresident, CEO & CFO
Transactions
- Sale
Lotus Bio-Technology Dev. Corp
2016-10-01$0.00/sh+50,000,000$50,000→ 0 total(indirect: Ex President/CEO)
Documents
Issuer
Lotus Biotech Development Corp.
CIK 0001520592
Entity typeoperating
IncorporatedWY
Related Parties
1- filerCIK 0001520592
Filing Metadata
- Form type
- 4/A
- Filed
- Oct 16, 8:00 PM ET
- Accepted
- Oct 17, 10:50 AM ET
- Size
- 4.7 KB